Wellington Santana da Silva Júnior

Universidade Federal do Maranhão · MA · 13 publicações em 2022–2025

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and ManagementDiabetes Management and ResearchAdipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and Treatment

Principais coautores no Nordeste tamanho = publicações em comum

Celi Marques-Santos Fernando M. A. Giuffrida Imara Correia de Queiroz Barbosa Iván Romero Rivera Larissa Neto Espíndola Maria Alayde Mendonça Rivera Maria Antonieta Albanez Albuquerque de Medeiros Lopes Milena dos Santos Barros Campos Regina Coeli Marques de Carvalho Thais de Carvalho Vieira Rodrigues Ruy Lyra Denise Maria Martins Vancea

Publicações recentes

2025 7

CARDIAL-MS (CArdio-Renal-DIAbetes-Liver-Metabolic Syndrome): a new proposition for an integrated multisystem metabolic disease
Medicina · Diabetology & Metabolic Syndrome
Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society
Medicina · Diabetology & Metabolic Syndrome
2025 Brazilian Evidence-based Guideline on the Management of Obesity and Prevention of Cardiovascular Disease and Obesity-Associated Complications: A Position Statement by Five Medical Societies
Medicina · Arquivos Brasileiros de Cardiologia
2025 Brazilian evidence-based guideline on the management of obesity and prevention of cardiovascular disease and obesity-associated complications: a position statement by five medical societies
Medicina · Diabetology & Metabolic Syndrome
Posicionamento sobre a Saúde Cardiometabólica ao Longo do Ciclo de Vida da Mulher – 2025
Medicina · Arquivos Brasileiros de Cardiologia
Position Statement on Cardiometabolic Health Across the Woman's Life Course – 2025
Medicina · Revista Brasileira Ginecologia e Obstetrícia
Position Statement on Cardiometabolic Health Across the Woman's Life Course – 2025
Medicina · Arquivos Brasileiros de Cardiologia

2024 3

2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes
Medicina · Diabetology & Metabolic Syndrome
Should the new EASL–EASD–EASO Clinical Practice Guidelines on MASLD recommend pioglitazone as a MASH-targeted pharmacotherapy?
Medicina · Journal of Hepatology
Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes
Medicina · Diabetology & Metabolic Syndrome

2023 2

2022: Position of Brazilian Diabetes Society on exercise recommendations for people with type 1 and type 2 diabetes
Medicina · Diabetology & Metabolic Syndrome
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes
Medicina · Diabetology & Metabolic Syndrome

2022 1

The 2021–2022 position of Brazilian Diabetes Society on insulin therapy in type 1 diabetes: an evidence-based guideline to clinical practice
Medicina · Diabetology & Metabolic Syndrome

Contagens só com publicações em revistas com Qualis (filtro na tela inicial). Dados obtidos de fontes abertas: OpenAlex (CC0), ROR (CC0), CAPES Dados Abertos (CC-BY), INEP e IBGE. Encontrou um erro sobre você? Saiba mais. Criado por Gabriel Pina.